Fig 1.
Flow diagram of PCM cases and their serological results.
DID: Double agar gel immunodiffusion test; ExoPb: P. brasiliensis exoantigen; gp43: purified 43 kDa glycoprotein; CFAPl: Cell free antigen from P. lutzii.
Fig 2.
Chest roentgenograms of three cases.
From left to right: mild, moderate, and severe.
Table 1.
Demographic findings of 81 paracoccidioidomycosis patients according to their serological profile.
Fig 3.
Distribution of 78 cases of paracoccidioidomycosis from the Mato Grosso do Sul state.
Fig 4.
Dendrograms related to the prevalence rates of paracoccidioidomycosis (PCM) per 100,000 inhabitants, January 2008—December 2012.
A. Group 1, PCM patients seropositive to gp43 and/or ExoPb and seronegative to CFAPl (51 cases). B. Group 2, PCM patients seronegative to gp43 and ExoPb and seropositive to CFAPl (16 cases). C. Group 3, PCM patients seropositive to gp43 or ExoPb and seropositive to CFAPl (11 cases). The reference year for the population was 2010.
Table 2.
PCM cases and prevalence rate (PR) per 100,000 inhabitants according to their municipalities and serological profiles.
Table 3.
Clinical aspects of 81 paracoccidioidomycosis patients according to their serological profiles.